Morning Market Losers

shares tumbled 29.04 percent to $3.03 after the company reported an offering of 2.5 million shares at $3.49 per share in registered direct public offering.

fell 19.79 percent to $10.50. ProQR Therapeutics reported a Q3 loss of $0.29 per share and issued an update on clinical trials.

shares dipped 18.12 percent to $1.31 after the company reported that it will raise $3.1 million via registered offering of shares and warrants.

fell 13.68 percent to $24.10 after the company reported a $74.8 million registered direct offering.

shares dropped 13.40 percent to $34.00 after the company reported weaker-than-expected results for the third quarter.

shares slipped 12.07 percent to $1.53 after the company reported intent to restate financial statements for years ended 2013, 2014 and first half of 2015.

shares declined 5.40 percent to $31.53. Raymond James downgraded Haemonetics from Market Perform to Underperform.

slipped 2.76 percent to $303.85.

agreed to buy Allergan in a $160 billion deal.